You are here

Novamind Inc.

Novamind Inc.
Listing Exchange: 
CSE
Status: 
Active
Symbol: 
NM
CSE Index: 
Currency: 

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.

You are here

Novamind Inc. (NM)

SEDAR Information

Company Info

Address
10 Wanless Avenue, Suite 201
Toronto, ON M4N 1V6
Canada
Phone
(647) 953 9512
Email
Contact@novamind.ca
Website
http://www.novamind.ca
Listing date
Tuesday, January 5, 2021
Transfer Agent
Marrelli Trust Company Limited
Investor Relations
Bill Mitoulas
Email
bill@novamind.ca
Auditor
DMCL LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
42,835,901
Reserved for Issuance: 
6,325,292

Company Officers

Yaron Conforti, Chief Executive Officer
Dr. Reid Robison, Chief Medical Officer
Dr. Paul Thielking, Chief Scientific Officer
Pierre Bou-Mansour, Chief Operating Officer
Jing Peng, Chief Financial Officer and Corporate Secretary

Bulletins

04/01/2021

2021-0102 - New Listing - Novamind Inc. (NM)

Le 4 janvier/January 2021

The common shares of Novamind Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-10-19_MJBizFinance_Website.jpg

MJBizFinance Forum

Tuesday, October 19, 2021 -
12:00pm to 8:00pm